4D Molecular Therapeutics, Inc. (FDMT)
USD 2.51
(-9.39%)
USD 2.51
(-9.39%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -76.37 Million USD | 2093.87% |
| 2022 | -751 Thousand USD | -105.0% |
| 2021 | 15.01 Million USD | 138.09% |
| 2020 | -39.42 Million USD | -24.25% |
| 2019 | -31.73 Million USD | -649.81% |
| 2018 | -4.23 Million USD | 45.63% |
| 2017 | -7.78 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -1.56 Million USD | 63.2% |
| 2024 Q2 | -1.61 Million USD | -3.38% |
| 2023 Q2 | -1.18 Million USD | -6.73% |
| 2023 Q4 | -4.25 Million USD | -122.62% |
| 2023 Q1 | -1.11 Million USD | -690.07% |
| 2023 FY | 14.97 Million USD | 2093.87% |
| 2023 Q3 | 18.8 Million USD | 1681.83% |
| 2022 Q1 | 437 Thousand USD | 124.35% |
| 2022 Q4 | -141 Thousand USD | 62.8% |
| 2022 Q3 | -379 Thousand USD | 43.35% |
| 2022 FY | -751 Thousand USD | -105.0% |
| 2022 Q2 | -669 Thousand USD | -253.09% |
| 2021 FY | 15.01 Million USD | 138.09% |
| 2021 Q4 | -1.79 Million USD | 87.6% |
| 2021 Q1 | -10.76 Million USD | 20.71% |
| 2021 Q3 | -14.47 Million USD | -2151.01% |
| 2021 Q2 | -643 Thousand USD | 94.03% |
| 2020 FY | -39.42 Million USD | -24.25% |
| 2020 Q4 | -13.58 Million USD | -228.54% |
| 2020 Q3 | -4.13 Million USD | 65.8% |
| 2020 Q2 | -12.08 Million USD | -25.61% |
| 2020 Q1 | -9.62 Million USD | 6.84% |
| 2019 Q3 | -8.83 Million USD | -40.57% |
| 2019 Q1 | -6.28 Million USD | -1049.95% |
| 2019 FY | -31.73 Million USD | -649.81% |
| 2019 Q4 | -10.32 Million USD | -16.92% |
| 2019 Q2 | -6.28 Million USD | 0.0% |
| 2018 FY | -4.23 Million USD | 45.63% |
| 2018 Q4 | -546.5 Thousand USD | 0.0% |
| 2018 Q3 | -546.5 Thousand USD | 65.18% |
| 2018 Q2 | -1.56 Million USD | 0.0% |
| 2018 Q1 | -1.56 Million USD | 0.0% |
| 2017 FY | -7.78 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 300.849% |
| Alkermes plc | 1.37 Billion USD | 105.556% |
| Agenus Inc. | 139.61 Million USD | 154.703% |
| Aptorum Group Limited | -1.11 Million USD | -6751.514% |
| Ardelyx, Inc. | 106.66 Million USD | 171.603% |
| Dyadic International, Inc. | 922.95 Thousand USD | 8374.817% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 462.628% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -43580.902% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -471.746% |
| Novavax, Inc. | 639.93 Million USD | 111.934% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -63.054% |
| Pyxis Oncology, Inc. | -2 Million USD | -3718.65% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -14679.602% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 501.056% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -172736.517% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -14392.03% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 22.241% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 9622.818% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -93037.805% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 156.46% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1070.309% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 21.224% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 105.032% |
| AlloVir, Inc. | -398 Thousand USD | -19089.196% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 131.725% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 18112.5% |
| Bicycle Therapeutics plc | -129.52 Million USD | 41.034% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 63744.167% |
| ChromaDex Corporation | 50.78 Million USD | 250.4% |
| Chimerix, Inc. | 324 Thousand USD | 23671.914% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -145.039% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 1.579% |
| CRISPR Therapeutics AG | 240.95 Million USD | 131.696% |
| Precision BioSciences, Inc. | 40.47 Million USD | 288.706% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 22.198% |
| Fortress Biotech, Inc. | 57.85 Million USD | 232.012% |
| Fortress Biotech, Inc. | 57.85 Million USD | 232.012% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 560.717% |
| ImmuCell Corporation | 4.39 Million USD | 1837.217% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 28.034% |
| Immix Biopharma, Inc. | -5468.00 USD | -1396626.408% |
| Incyte Corporation | 3.44 Billion USD | 102.22% |
| Innoviva, Inc. | 261.06 Million USD | 129.254% |
| IO Biotech, Inc. | -756 Thousand USD | -10002.249% |
| Jaguar Health, Inc. | 7.72 Million USD | 1088.775% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -11401.958% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 163.775% |
| ContextLogic Inc. | 59 Million USD | 229.446% |
| MiMedx Group, Inc. | 266.84 Million USD | 128.621% |
| MEI Pharma, Inc. | 49.32 Million USD | 254.83% |
| NextCure, Inc. | -3.68 Million USD | -1973.1% |
| Onconetix, Inc. | -1.12 Million USD | -6675.672% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -163.646% |
| Opthea Limited | 21.72 Thousand USD | 351725.23% |
| Psyence Biomedical Ltd. | -240.00 USD | -31821983.333% |
| Vaxcyte, Inc. | -75 Million USD | -1.831% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -133125.761% |
| Precigen, Inc. | 106 Thousand USD | 72150.0% |
| Pharming Group N.V. | 220.1 Million USD | 134.699% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 14929.709% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 7669.177% |
| PureTech Health plc | -1.6 Million USD | -4664.379% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 169.574% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 57.9% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -68.501% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -247.355% |
| Acelyrin, Inc. | -115 Thousand USD | -66311.304% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -759754.741% |
| Summit Therapeutics Inc. | -2.05 Million USD | -3625.512% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -13275.306% |
| Senti Biosciences, Inc. | -2.68 Million USD | -2746.552% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1985.288% |
| Elevation Oncology, Inc. | -39 Thousand USD | -195728.205% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1491.767% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -1837.394% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 362.189% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 15497.782% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -138760.0% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 173.366% |
| Seer, Inc. | 7.02 Million USD | 1186.851% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1844.472% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 454.481% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -64354.684% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -53195.511% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 12640.722% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 163.394% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 124.348% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1527360.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 3067.094% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -150418.329% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 359.887% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -32819.397% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -15422.967% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -975.979% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -15993.943% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -734255.769% |
| Soligenix, Inc. | 97.31 Thousand USD | 78583.419% |
| Century Therapeutics, Inc. | -10.8 Million USD | -606.569% |
| Kura Oncology, Inc. | -849 Thousand USD | -8895.642% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -13.813% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -51854.422% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 177.114% |
| Autolus Therapeutics plc | -4.86 Million USD | -1469.201% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 284.538% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -45360.119% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 180.628% |
| GRI Bio, Inc. | 10.84 Million USD | 804.483% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 3106.828% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -779.164% |
| IGM Biosciences, Inc. | -211.66 Million USD | 63.917% |
| INmune Bio, Inc. | 155 Thousand USD | 49372.903% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 223.304% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -4970.269% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -11677.705% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -260790.21% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 19098.259% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -3726.303% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -24300.319% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 180.851% |
| Verastem, Inc. | -62 Thousand USD | -123082.258% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 3236.468% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -29161.686% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 2623.059% |
| Histogen Inc. | 3.76 Million USD | 2126.347% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 13355.082% |
| Surrozen, Inc. | -27.23 Million USD | -180.474% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1317.202% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -6238.64% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -197.785% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 480.875% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -3857122.222% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1358.946% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -113667.112% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 149.339% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 52482.03% |
| Apollomics, Inc. | 127 Thousand USD | 60236.22% |
| Amarin Corporation plc | 165.54 Million USD | 146.135% |
| Mesoblast Limited | -9.81 Million USD | -678.125% |
| Turnstone Biologics Corp. | 16.5 Million USD | 562.698% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 30.877% |
| Synaptogenix, Inc. | -6347.00 USD | -1203192.894% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -149650.98% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 147.329% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 104.345% |
| Better Therapeutics, Inc. | -2.72 Million USD | -2698.571% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 31.908% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 122.59% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -669368.794% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1120.016% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -6792.87% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1143.632% |
| Insmed Incorporated | 239.63 Million USD | 131.871% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 2234.516% |
| OmniAb, Inc. | 14.66 Million USD | 620.713% |
| Alector, Inc. | -95.05 Million USD | 19.652% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 160.796% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -75.72% |
| Zai Lab Limited | 170.9 Million USD | 144.688% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 193.278% |
| Aura Biosciences, Inc. | -1.29 Million USD | -5797.529% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 58848.462% |
| Immunic, Inc. | -111 Thousand USD | -68704.505% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 581.727% |
| Veracyte, Inc. | 248.14 Million USD | 130.777% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.907% |
| FibroGen, Inc. | 128.9 Million USD | 159.248% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -13541212.057% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -554.613% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 102.247% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 19733.162% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 121.493% |
| TG Therapeutics, Inc. | 219.1 Million USD | 134.856% |
| Galecto, Inc. | -830 Thousand USD | -9101.566% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -5414.296% |
| Fortrea Holdings Inc. | 424 Million USD | 118.013% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 11.366% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -13369.665% |
| XBiotech Inc. | -1.74 Million USD | -4279.186% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -6792.87% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -64.346% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -1.111% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 204.046% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 554.52% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 119.631% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -53.832% |
| Vaxxinity, Inc. | -2.23 Million USD | -3318.666% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 123.373% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -574.444% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 412.351% |
| NexImmune, Inc. | -1.02 Million USD | -7351.228% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1414414.815% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -974.82% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.676% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -114184.645% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -2050.746% |
| Ainos, Inc. | -253.73 Thousand USD | -29999.751% |
| Pluri Inc. | 322 Thousand USD | 23818.323% |
| Prothena Corporation plc | -129.2 Million USD | 40.888% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 251.462% |
| Celularity Inc. | 6.75 Million USD | 1230.614% |
| Rallybio Corporation | -150 Thousand USD | -50815.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | -134.223% |
| MeiraGTx Holdings plc | 287 Thousand USD | 26710.801% |
| Omeros Corporation | -69.77 Million USD | -9.45% |
| Humacyte, Inc. | -76.55 Million USD | 0.231% |
| Immunocore Holdings plc | 248.39 Million USD | 130.747% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -403.481% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 222.428% |
| Blueprint Medicines Corporation | 236.58 Million USD | 132.282% |
| CalciMedica, Inc. | -58 Thousand USD | -131577.586% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -5255.75% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 362.857% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -2585.408% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -147.442% |
| Pulmatrix, Inc. | -8.22 Million USD | -829.112% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -6427.607% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -19041.103% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 80.849% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 2851.6% |
| Cytokinetics, Incorporated | -322.59 Million USD | 76.325% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 8958.898% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -22296.774% |
| Vor Biopharma Inc. | -3.49 Million USD | -2087.085% |
| Roivant Sciences Ltd. | 109.23 Million USD | 169.916% |
| Evogene Ltd. | 1.39 Million USD | 5559.114% |
| ProKidney Corp. | -3.16 Million USD | -2310.003% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -73.923% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1213.796% |
| CorMedix Inc. | -205.56 Thousand USD | -37053.268% |
| BioLineRx Ltd. | 1.1 Million USD | 6992.87% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 2.921% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -231333.333% |
| Atai Life Sciences N.V. | -5000.00 USD | -1527360.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -62573.254% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -79455.208% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -5398.416% |
| Sagimet Biosciences Inc. | 2 Million USD | 3918.65% |
| MediciNova, Inc. | 979.7 Thousand USD | 7895.51% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 9.424% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -80670.98% |
| GeoVax Labs, Inc. | -20.72 Million USD | -268.582% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 131.232% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1717.972% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 108.755% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1128.454% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -24536.452% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -636341.667% |
| Absci Corporation | -41.84 Million USD | -82.497% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1527360.0% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -3003.332% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 135.733% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -8016.153% |
| Allakos Inc. | -6.14 Million USD | -1143.657% |
| Imunon, Inc. | -720 Thousand USD | -10507.287% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -10.692% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 116.048% |
| BioAtla, Inc. | -103.73 Million USD | 26.374% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -669368.794% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -42806.18% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 68.547% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -24457.235% |
| XOMA Corporation | 3.86 Million USD | 2078.063% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -8.972% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 616.243% |
| aTyr Pharma, Inc. | -2.38 Million USD | -3098.199% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 712.945% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -263255.172% |
| Viridian Therapeutics, Inc. | -1 Million USD | -7476.687% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 587484715.385% |
| Akari Therapeutics, Plc | -4000.00 USD | -1909225.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 111.992% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 39324.377% |
| UroGen Pharma Ltd. | 73.35 Million USD | 204.118% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -186.105% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 657920.844% |
| Orgenesis Inc. | -5.72 Million USD | -1234.026% |
| Entera Bio Ltd. | -56 Thousand USD | -136280.357% |
| GH Research PLC | -315 Thousand USD | -24145.397% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -40308.995% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -14447.238% |
| Xencor, Inc. | -85.26 Million USD | 10.423% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -34461.515% |
| Replimune Group, Inc. | -2.65 Million USD | -2776.573% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -7527.872% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 142.944% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 39324.377% |
| Portage Biotech Inc. | -54 Thousand USD | -141331.481% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -80670.98% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -20158.09% |
| OncoCyte Corporation | 413 Thousand USD | 18592.252% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1698965.628% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -34402152.252% |
| Purple Biotech Ltd. | -196 Thousand USD | -38865.816% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 951.617% |
| scPharmaceuticals Inc. | 9.78 Million USD | 880.75% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -631.195% |
| HilleVax, Inc. | -2.15 Million USD | -3442.347% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -78635.052% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -508917.595% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -11333.084% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -331956.522% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1017370.984% |
| Savara Inc. | -44.26 Million USD | -72.548% |
| Curis, Inc. | 9.81 Million USD | 878.443% |
| Daré Bioscience, Inc. | 2.76 Million USD | 2857.624% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -61102.199% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -4317.178% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -33396.93% |
| BeiGene, Ltd. | 2.07 Billion USD | 103.674% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -2631.607% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 80.891% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 234.725% |
| Erasca, Inc. | -3.73 Million USD | -1946.436% |
| bluebird bio, Inc. | -4.03 Million USD | -1795.112% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -270553.484% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 104.01% |
| DBV Technologies S.A. | 15.72 Million USD | 585.586% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -270553.484% |
| Moderna, Inc. | 2.15 Billion USD | 103.544% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -8246.776% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1053.947% |
| Molecular Templates, Inc. | 50.39 Million USD | 251.549% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -14148.694% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 157.085% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1127.467% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -94.121% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 31.275% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2028.567% |
| MacroGenics, Inc. | 50.52 Million USD | 251.153% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1152.427% |
| Prime Medicine, Inc. | -147.9 Million USD | 48.363% |
| Aditxt, Inc. | -111.66 Thousand USD | -68297.815% |
| Adagene Inc. | 18.11 Million USD | 521.683% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 15750.205% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 154.474% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 148.388% |
| SciSparc Ltd. | 2.19 Million USD | 3577.823% |
| Vericel Corporation | 135.57 Million USD | 156.332% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -304794.407% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -246407.65% |
| Generation Bio Co. | -73.91 Million USD | -3.331% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -17376.659% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 239.829% |
| Invivyd, Inc. | -2.02 Million USD | -3665.927% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 74.614% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -73734.568% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 179.251% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 177.703% |
| ADMA Biologics, Inc. | 88.21 Million USD | 186.573% |
| Clene Inc. | 533 Thousand USD | 14428.893% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 416.78% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -7880.46% |
| GeoVax Labs, Inc. | -20.72 Million USD | -268.582% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 3941.7% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -39203.506% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 253.344% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -976.889% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -9035.526% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 191.558% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 104560.28% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 243.661% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 55.902% |
| Trevena, Inc. | 1.45 Million USD | 5349.003% |
| Surrozen, Inc. | -27.23 Million USD | -180.474% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -21535.411% |
| Cingulate Inc. | -582.91 Thousand USD | -13001.843% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -246264.516% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -287.7% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1008790.357% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -8568.899% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 111.22% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -7630.061% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -135452.519% |
| Kronos Bio, Inc. | 1.37 Million USD | 5666.545% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -42.312% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -26055.137% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -15540.141% |
| ImmunityBio, Inc. | -17.89 Million USD | -326.903% |
| Korro Bio, Inc. | -3.63 Million USD | -2003.939% |
| Kineta, Inc. | 5.43 Million USD | 1505.724% |
| BioVie Inc. | -229.37 Thousand USD | -33195.84% |
| Codexis, Inc. | 57.33 Million USD | 233.207% |
| Celularity Inc. | 6.75 Million USD | 1230.614% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2003.14% |
| Celcuity Inc. | -142.77 Thousand USD | -53392.982% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 151064.618% |
| Cibus, Inc. | 1.42 Million USD | 5470.816% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -20320.588% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -233.23% |
| IN8bio, Inc. | -2.5 Million USD | -2953.699% |
| Kodiak Sciences Inc. | -25.94 Million USD | -194.342% |
| Annexon, Inc. | -3.26 Million USD | -2237.71% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -3636.448% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -82.986% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 12033.281% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 109.81% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 144.158% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -3919.632% |
| Arcellx, Inc. | 108.27 Million USD | 170.534% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -135.945% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 196.426% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -261.068% |
| Moolec Science SA | -143.3 Thousand USD | -53194.023% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -80.474% |
| Geron Corporation | -123.5 Million USD | 38.161% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 2423.486% |
| Royalty Pharma plc | 1.79 Billion USD | 104.257% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -8.964% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -2114324.142% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 33106.037% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 31.451% |
| Humacyte, Inc. | -76.55 Million USD | 0.231% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -7946.259% |
| 89bio, Inc. | -273 Thousand USD | -27875.458% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -5975.815% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -8906.25% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -61991.87% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 6925.112% |
| Notable Labs, Ltd. | 113 Thousand USD | 67686.726% |
| Liquidia Corporation | 14.6 Million USD | 623.103% |
| Mustang Bio, Inc. | -2.22 Million USD | -3332.494% |
| Immunovant, Inc. | -231 Thousand USD | -32961.905% |
| Quantum-Si incorporated | 488 Thousand USD | 15750.205% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -37.463% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -254476.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 4201.665% |
| Acasti Pharma Inc. | -11 Thousand USD | -694200.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -37224.856% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -11677.705% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 54.407% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 6831.39% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -19945.407% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -3800.562% |
| PepGen Inc. | -1.18 Million USD | -6350.422% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -60036.22% |
| United Therapeutics Corporation | 2.07 Billion USD | 103.69% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -233.55% |
| Solid Biosciences Inc. | -76.56 Million USD | 0.248% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -92380.293% |
| Immuneering Corporation | -764.13 Thousand USD | -9894.661% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 115355.644% |
| Belite Bio, Inc | -399 Thousand USD | -19041.103% |
| XOMA Corporation | 3.86 Million USD | 2078.063% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -281.179% |
| Bionomics Limited | -434.44 Thousand USD | -17479.279% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7011.08% |
| uniQure N.V. | 2.21 Million USD | 3547.991% |
| Cassava Sciences, Inc. | -89.42 Million USD | 14.594% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 17.048% |
| Forte Biosciences, Inc. | -9000.00 USD | -848488.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -9046.467% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -17376.659% |
| Altimmune, Inc. | -65.37 Million USD | -16.827% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 121.096% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7011.08% |
| Compugen Ltd. | 31.45 Million USD | 342.801% |
| Peak Bio, Inc. | 367.76 Thousand USD | 20866.568% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 411.523% |
| Benitec Biopharma Inc. | 108 Thousand USD | 70815.741% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -97814.103% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -6248.545% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -4091.712% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -64078.992% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -6248.545% |
| Instil Bio, Inc. | -4.75 Million USD | -1505.824% |
| argenx SE | 1.1 Billion USD | 106.89% |
| Immunome, Inc. | -8.9 Million USD | -757.449% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -3940.899% |
| Verona Pharma plc | -679.62 Thousand USD | -11137.537% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -43541.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | -3102.222% |
| CervoMed Inc. | -1.29 Million USD | -5803.788% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -3072.954% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1498.765% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 3190.773% |
| Moolec Science SA | -143.3 Thousand USD | -53194.023% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -18617.496% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -2758.776% |
| AnaptysBio, Inc. | 14.78 Million USD | 616.697% |
| Design Therapeutics, Inc. | -537 Thousand USD | -14122.16% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -17785.948% |
| NeurAxis, Inc. | 2.15 Million USD | 3641.191% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 3658.854% |
| Lumos Pharma, Inc. | 2 Million USD | 3905.331% |
| Achilles Therapeutics plc | -4.73 Million USD | -1514.219% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -43541.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -72171.587% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 341.238% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 8958.898% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -7300.484% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -67.676% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 177711.628% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -9191.119% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -580330.157% |
| Palisade Bio, Inc. | 246 Thousand USD | 31145.935% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -231333.333% |
| Beam Therapeutics Inc. | -59.67 Million USD | -27.988% |
| Neurogene Inc. | -3.26 Million USD | -2241.294% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 154.813% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1968.608% |
| Sesen Bio, Inc. | 40 Million USD | 290.933% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -25614.815% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1796.506% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -698.38% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 642.422% |
| Athira Pharma, Inc. | -969 Thousand USD | -7781.631% |
| Vaccinex, Inc. | -16 Million USD | -377.212% |
| HCW Biologics Inc. | -574.82 Thousand USD | -13186.328% |
| XOMA Corporation | 3.86 Million USD | 2078.063% |
| Nektar Therapeutics | 53.47 Million USD | 242.812% |
| Arvinas, Inc. | 71.8 Million USD | 206.369% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 8.493% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -21.661% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -23618.323% |
| Rezolute, Inc. | -36 Thousand USD | -212047.222% |
| Clene Inc. | 533 Thousand USD | 14428.893% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -5947952.96% |
| BeyondSpring Inc. | 1.75 Million USD | 4461.679% |
| Synlogic, Inc. | -1.92 Million USD | -3869.491% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -206313.514% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1106.143% |
| Peak Bio, Inc. | 367.76 Thousand USD | 20866.568% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -302.747% |
| Krystal Biotech, Inc. | 47.6 Million USD | 260.431% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 154.13% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1619.861% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -2849.654% |
| MannKind Corporation | 136.19 Million USD | 156.078% |
| Ikena Oncology, Inc. | -50.49 Million USD | -51.258% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 170.187% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1641.688% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -30206.746% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1527360.0% |
| Legend Biotech Corporation | 140.92 Million USD | 154.193% |
| Mural Oncology plc | -2.56 Million USD | -2875.185% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -13760.799% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -76273.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 467.992% |
| REGENXBIO Inc. | 53.02 Million USD | 244.021% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1325.68% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -39600.065% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -4309.527% |
| Vaxart, Inc. | -60.76 Million USD | -25.69% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -28963.475% |
| Cellectis S.A. | 18 Thousand USD | 424394.444% |
| Longeveron Inc. | 221 Thousand USD | 34657.919% |
| Repare Therapeutics Inc. | -80.07 Million USD | 4.617% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 106.988% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -5802.087% |
| Revolution Medicines, Inc. | -399.66 Million USD | 80.891% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -218108.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 155963.265% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.887% |
| Denali Therapeutics Inc. | -93.34 Million USD | 18.182% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -304794.407% |
| Veru Inc. | 7.56 Million USD | 1109.433% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -50478.146% |
| Cingulate Inc. | -582.91 Thousand USD | -13001.843% |
| Passage Bio, Inc. | -3.72 Million USD | -1952.486% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -634016.573% |
| Exicure, Inc. | -1.42 Million USD | -5267.041% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -19840.731% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 2925.49% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -14796.962% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 212.106% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -50949.082% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -28.995% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 19632.737% |
| OmniAb, Inc. | 14.66 Million USD | 620.713% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 481.999% |
| Lipocine Inc. | -2.85 Million USD | -2578.985% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -4043.95% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1238.703% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -4970.269% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 201.403% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -117396.923% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 190.601% |
| Ocugen, Inc. | -33.53 Million USD | -127.728% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -2315.338% |
| Q32 Bio Inc. | 578 Thousand USD | 13313.322% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -28720.0% |
| Alumis Inc. Common Stock | -1.28 Million USD | -5848.053% |
| Equillium, Inc. | 35.95 Million USD | 312.395% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -4374.107% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 15353.885% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1847335.897% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -29387.645% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 18167.384% |
| Dominari Holdings Inc. | 2.03 Million USD | 3845.611% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -41526.742% |
| vTv Therapeutics Inc. | -13.59 Million USD | -461.773% |
| Bio-Techne Corporation | 773.07 Million USD | 109.879% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 540.978% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 116.575% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -6433.191% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -218.486% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 752.928% |
| Nkarta, Inc. | -5.86 Million USD | -1201.295% |
| BioCardia, Inc. | -7.24 Million USD | -953.566% |
| Iterum Therapeutics plc | -1.75 Million USD | -4264.171% |